Table 3.
Top 10 productive corresponding author country in Covid-19 and vaccine safety research
SCR | Country (n = 80) | NP | TC | AAC | SCP | MCP | MCP_Ratio |
---|---|---|---|---|---|---|---|
1 | USA | 380 | 7677 | 20.203 | 307 | 73 | 0.192a |
2 | China | 121 | 3039 | 25.116 | 78 | 43 | 0.355a |
3 | India | 101 | 834 | 8.257 | 82 | 19 | 0.188a |
4 | United Kingdom | 94 | 2165 | 23.032 | 58 | 36 | 0.383a |
5 | Italy | 89 | 446 | 5.011 | 70 | 19 | 0.213a |
6 | Canada | 46 | 426 | 9.261 | 34 | 12 | 0.261a |
7 | Australia | 45 | 387 | 8.600 | 23 | 22 | 0.489a |
8 | Germany | 28 | 148 | 5.286 | 17 | 11 | 0.393a |
9 | Spain | 26 | 89 | 3.423 | 18 | 8 | 0.308a |
10 | France | 25 | 187 | 7.480 | 17 | 8 | 0.320a |
SCR: Standard Competition Ranking; TC: Total Citations, NP: Number of publications; AAC: Average Article Citations: SCP: Single Country Publication (intra-country collaboration). MCP: Multiple Country Publications (inter-country collaboration). a: Lower International Collaboration (Value: Less 0,50).